Teen Options to Prevent Pregnancy (T.O.P.P.)
The program was designed for and evaluated through home- and telephone-based care coordination delivered by trained nurses in Ohio.
Robyn Lutz
Project director
Phone: 614-566-9085
Email: Robyn.Lutz@ohiohealth.com
Robyn Lutz
Project director
Ph: 614-566-9085
Email: Robyn.Lutz@ohiohealth.com
Motivational interviewing: 18 monthly one-on-one home and telephone motivational interviewing sessions with a nurse educator focusing on birth spacing and preventing repeat pregnancy, birth control methods and misconceptions about the methods, and future planning for achieving birth control and spacing goals.
Access to contraception: T.O.P.P. improves access to
contraception by offering access to a T.O.P.P. clinic, transportation services, and/or in-person discussion about and distribution of contraceptives.
During the nurse educators’ contacts with participants, they use motivational interviewing, to educate clients about family planning and the value of preventing rapid repeat pregnancies. Educators strive to gently guide the conversation in a manner that educates participants about the health benefits of delaying subsequent pregnancy, provides medically-accurate information on various birth control methods (including abstinence), addresses any misconceptions inhibiting contraceptive use, and helps the teens develop a birth control plan.
Follow-up telephone calls provide an opportunity to provide further information on contraceptives, help participants identify and schedule appointments with their OB/GYN or other
medical provider, debrief about the participants’ appointments, and problem-solve barriers to consistent and continued birth control use.
The calls also provide a forum for the educators to address supportive service needs participants may face, and refer them to the T.O.P.P. social worker for additional support, as needed.
Participants may also access birth control through the T.O.P.P. Clinic if they cannot get into their clinic or medical home. Nurses also provide in home Depo Provera shots.
Citation | High-Quality Randomized Trial | Moderate-Quality Randomized Trial | Moderate-Quality Quasi-experiment | Low Study Rating | Did Not Meet Eligibility Criteria |
---|---|---|---|---|---|
Smith et al. 2015a Rotz et al. 2016a Stevens et al., 2017 |
✓ |
Citation | Setting | Majority Age Group | Majority Racial/Ethnic Group | Gender | Sample Size |
---|---|---|---|---|---|
Smith et al. 2015a Rotz et al. 2016a Stevens et al., 2017 |
Multiple settings | 18 or 19 | White | Young women | 493 |
Evidence by Outcome Domain and Study
Citation | Sexual Activity | Number of Sexual Partners | Contraceptive Use | STIs or HIV | Pregnancy |
---|---|---|---|---|---|
Smith et al. 2015a Rotz et al. 2016a Stevens et al., 2017 |
![]() |
![]() |
![]() |
n.a. |
![]() |
Citation | Details |
---|---|
Smith et al. 2015a Rotz et al. 2016a Stevens et al., 2017 |
The program was evaluated using a randomized controlled trial involving pregnant or recently pregnant young women recruited from seven obstetrics-gynecology clinics and five postpartum units of a large hospital system in a Midwestern city. Participants were randomly assigned to either a treatment group that received the 18-month T.O.P.P. program or a control group that received usual care. Surveys were administered at baseline, mid-intervention (6 months after enrollment), and immediately after the end of the intervention (18 months after enrollment). The study found that adolescents participating in the intervention were significantly less likely to report having had unprotected vaginal intercourse in the past three months at six months after enrollment (effect size = .02) and at 18 months after enrollment (effect size = 0.01). The study also found that 18 months after enrollment, adolescents participating in T.O.P.P. were significantly less likely to report having had a repeat pregnancy (effect size = 0.01), unintended repeat pregnancy (effect size = 0.02), or live birth (effect size = 0.03) since enrollment. At both six and 18 months after study enrollment, the study found no statistically significant program impacts on whether the participant had vaginal sex, whether the participant had vaginal intercourse without a condom, or the number of sexual partners in the past three months. The study also examined program impacts on measures of use of long-acting reversible contraception, use of effective birth control, trying to avoid pregnancy in the next year, school enrollment, and completion of high school or GED. Findings for these outcomes were not considered for the review because they fell outside the scope of the review. |